ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,670.30
0.21%
Gold vs US Dollar
2,316.71
-0.70%
Brent Oil
83.325
1.46%
Bitcoin
66,011.22
-0.94%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Alterity Therapeutics Ltd (PK) (PRNAF)

  7. Alterity Therapeutics Ltd (PK) (PRNAF) News

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PRNAF
DateTimeSourceHeadlineSymbolCompany
04/03/202413:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/03/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
06/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/12/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
11/12/202311:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/12/202311:39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/11/202302:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
27/11/202311:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202313:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202313:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/11/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/10/202310:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/10/202312:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/10/202313:44Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersUSOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202317:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202315:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202314:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202302:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
23/08/202311:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
 Showing the most relevant articles for your search:USOTC:PRNAF

Your Recent History

LSE
EEE
Empire Metals
LSE
BT.A
Bt
LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
ARCM
Arc Minerals
LSE
VAST
Vast Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
THG
Thg
LSE
SOLG
Solgold
LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
SDRY
Superdry
LSE
LBE
Longboat Energy
LSE
GOLD
LSE
KEFI
Kefi Gold And Copper
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved